{"id":"https://openalex.org/W4362619441","doi":"https://doi.org/10.1158/2326-6066.22543962","title":"Supplementary Figures from A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes V\u03b39V\u03b42 T cell\u2013Mediated Antitumor Responses in Human B-cell Malignancies","display_name":"Supplementary Figures from A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes V\u03b39V\u03b42 T cell\u2013Mediated Antitumor Responses in Human B-cell Malignancies","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362619441","doi":"https://doi.org/10.1158/2326-6066.22543962"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.22543962","doi":"https://doi.org/10.1158/2326-6066.22543962","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.22543962","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2326-6066.22543962","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010497761","display_name":"Iris de Weerdt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iris de Weerdt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010947873","display_name":"Roeland Lameris","orcid":"https://orcid.org/0000-0003-4729-8863","observed_orcids":["https://orcid.org/0000-0003-4729-8863"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roeland Lameris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109907966","display_name":"George L. Scheffer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George L. Scheffer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071988550","display_name":"Jana Vree","orcid":"https://orcid.org/0000-0001-7871-5952","observed_orcids":["https://orcid.org/0000-0001-7871-5952"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jana Vree","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7871-5952","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050120015","display_name":"Renate de Boer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renate de Boer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090485001","display_name":"Anita G.M. Stam","orcid":"https://orcid.org/0000-0003-4667-509X","observed_orcids":["https://orcid.org/0000-0003-4667-509X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anita G. Stam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065216070","display_name":"Rieneke van de Ven","orcid":"https://orcid.org/0000-0002-4230-8383","observed_orcids":["https://orcid.org/0000-0002-4230-8383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rieneke van de Ven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004217461","display_name":"Mark\u2010David Levin","orcid":"https://orcid.org/0000-0003-2139-3547","observed_orcids":["https://orcid.org/0000-0003-2139-3547"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark-David Levin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2139-3547","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032324734","display_name":"Steven T. Pals","orcid":"https://orcid.org/0000-0002-1419-0939","observed_orcids":["https://orcid.org/0000-0002-1419-0939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven T. Pals","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030757583","display_name":"Rob C. Roovers","orcid":"https://orcid.org/0000-0002-9715-2136","observed_orcids":["https://orcid.org/0000-0002-9715-2136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rob C. Roovers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039190287","display_name":"Paul W.H.I. Parren","orcid":"https://orcid.org/0000-0002-4365-3859","observed_orcids":["https://orcid.org/0000-0002-4365-3859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul W.H.I. Parren","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4365-3859","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053105927","display_name":"Tanja D. de Gruijl","orcid":"https://orcid.org/0000-0003-1464-8978","observed_orcids":["https://orcid.org/0000-0003-1464-8978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanja D. de Gruijl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064164625","display_name":"Arnon Philip Kater","orcid":"https://orcid.org/0000-0003-3190-1891","observed_orcids":["https://orcid.org/0000-0003-3190-1891"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arnon P. Kater","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5039649967","display_name":"Hans J. van der Vliet","orcid":"https://orcid.org/0000-0001-7846-8613","observed_orcids":["https://orcid.org/0000-0001-7846-8613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans J. van der Vliet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.47749999165534973,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.47749999165534973,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.319599986076355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.06350000202655792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cd40-signaling","display_name":"CD40 signaling","score":0.9660000205039978},{"id":"https://openalex.org/keywords/prosurvival-signaling","display_name":"survival signaling","score":0.8550000190734863},{"id":"https://openalex.org/keywords/vgamma9vdelta2-t-cells","display_name":"V\u03b39V\u03b42 T cells","score":0.9860000014305115},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7960000038146973},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.9629999995231628},{"id":"https://openalex.org/keywords/t-cell-mediated-immunity","display_name":"T cell immunity","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5545352697372437},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5246855616569519},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.5239648818969727},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.5128896236419678},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4641507863998413},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.42373138666152954},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38331323862075806},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3687508702278137},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.36411023139953613},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31270933151245117},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.18839365243911743},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.14046844840049744},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.13868650794029236},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0759894847869873},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06439366936683655}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/2326-6066.22543962","doi":"https://doi.org/10.1158/2326-6066.22543962","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.22543962","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2326-6066.22543962.v1","doi":"https://doi.org/10.1158/2326-6066.22543962.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.22543962.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/40007370","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22543962","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_from_A_Bispecific_Antibody_Antagonizes_Prosurvival_CD40_Signaling_and_Promotes_V_9V_2_T_cell_Mediated_Antitumor_Responses_in_Human_B-cell_Malignancies/22543962","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.22543962","doi":"https://doi.org/10.1158/2326-6066.22543962","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2326-6066.22543962","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362619441.pdf","grobid_xml":"https://content.openalex.org/works/W4362619441.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3105835028","https://openalex.org/W4362525178","https://openalex.org/W4362620459","https://openalex.org/W7165013685","https://openalex.org/W2032334754"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-07T00:00:00"}